Avience Biomedicals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	49.37	3.57	2.45	0.25	0.7
Cash & Short-Term Investments	49.37	3.57	2.45	0.25	0.7
Cash Growth	1283.55%	45.77%	883.44%	-64.55%	-
Accounts Receivable	172.12	80.91	18.07	25.3	4.9
Other Receivables	0.9	0.6	0.07	-	-
Receivables	176.12	84.1	20.21	25.3	4.9
Inventory	130.71	123.95	35.44	14.69	2.77
Prepaid Expenses	1.66	0.06	0.04	-	-
Other Current Assets	13.89	18.73	10.68	5.38	2.53
Total Current Assets	371.73	230.4	68.81	45.61	10.9
Property, Plant & Equipment	176.14	101.46	25.18	11.63	5.33
Long-Term Investments	0.51	2.88	1.12	-	-
Goodwill	1.45	1.45	-	-	-
Long-Term Deferred Tax Assets	0.74	1.08	-	-	-
Other Long-Term Assets	14.68	9.24	5.03	3.68	2.27
Total Assets	565.25	346.51	100.15	60.93	18.5
Accounts Payable	72.68	55.49	12.72	2.29	1.66
Accrued Expenses	10.11	5.21	1.19	0.86	0.17
Short-Term Debt	114.99	69.75	24.87	23.18	5.8
Current Portion of Long-Term Debt	8.1	8.71	0.21	-	-
Current Income Taxes Payable	23.88	6.63	0.59	0.81	0.03
Current Unearned Revenue	1.5	1.5	-	-	-
Other Current Liabilities	3.08	60.72	17.76	3.8	0.22
Total Current Liabilities	234.33	208.02	57.34	30.94	7.87
Long-Term Debt	98.5	72.84	1.49	1.7	-
Pension & Post-Retirement Benefits	2.25	2.18	-	0.02	-
Long-Term Deferred Tax Liabilities	1.49	1.19	0.54	0.21	0.05
Other Long-Term Liabilities	0.16	0	0.1	0.14	0.02
Total Liabilities	336.72	284.23	59.47	33.01	7.95
Common Stock	40.31	32.85	32.85	20.35	10.1
Additional Paid-In Capital	85.88	-	-	-	-
Retained Earnings	102.34	29.43	7.83	7.58	0.45
Comprehensive Income & Other	-0	-	-	-	-
Shareholders' Equity	228.53	62.28	40.68	27.92	10.55
Total Liabilities & Equity	565.25	346.51	100.15	60.93	18.5
Total Debt	221.58	151.31	26.57	24.88	5.8
Net Cash (Debt)	-172.22	-147.74	-24.12	-24.64	-5.1
Net Cash Per Share	-45.39	-44.98	-9.04	-18.31	-81.37
Filing Date Shares Outstanding	4.03	3.28	3.28	2.64	0.06
Total Common Shares Outstanding	4.03	3.28	3.28	2.64	0.06
Working Capital	137.4	22.38	11.47	14.67	3.03
Book Value Per Share	56.69	18.96	12.38	10.59	168.34
Tangible Book Value	227.08	60.83	40.68	27.92	10.55
Tangible Book Value Per Share	56.33	18.52	12.38	10.59	168.34
Land	45.74	40.99	-	-	-
Machinery	112.31	84.18	28.32	12.68	5.41
Construction In Progress	46.19	0.28	-	-	-